Range Financial Group’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $660K | Buy |
17,198
+8,063
| +88% | +$310K | 0.26% | 106 |
|
|
2025
Q1 | $354K | Buy |
9,135
+652
| +8% | +$25.3K | 0.16% | 135 |
|
|
2024
Q4 | $287K | Buy |
+8,483
| New | +$287K | 0.13% | 154 |
|
|
2024
Q3 | – | Sell |
-10,895
| Closed | -$419K | – | 121 |
|
|
2024
Q2 | $419K | Sell |
10,895
-124
| -1% | -$4.77K | 0.21% | 119 |
|
|
2024
Q1 | $472K | Buy |
11,019
+1,117
| +11% | +$47.9K | 0.25% | 114 |
|
|
2023
Q4 | $367K | Sell |
9,902
-870
| -8% | -$32.2K | 0.22% | 122 |
|
|
2023
Q3 | $390K | Sell |
10,772
-501
| -4% | -$18.2K | 0.26% | 114 |
|
|
2023
Q2 | $402K | Sell |
11,273
-135
| -1% | -$4.81K | 0.26% | 121 |
|
|
2023
Q1 | $406K | Buy |
11,408
+1,889
| +20% | +$67.2K | 0.27% | 122 |
|
|
2022
Q4 | $334K | Sell |
9,519
-1,197
| -11% | -$42.1K | 0.23% | 142 |
|
|
2022
Q3 | $315K | Buy |
10,716
+1,473
| +16% | +$43.3K | 0.24% | 128 |
|
|
2022
Q2 | $503K | Sell |
9,243
-208
| -2% | -$11.3K | 0.37% | 110 |
|
|
2022
Q1 | $515K | Buy |
9,451
+154
| +2% | +$8.39K | 0.33% | 107 |
|
|
2021
Q4 | $512K | Buy |
9,297
+111
| +1% | +$6.11K | 0.34% | 105 |
|
|
2021
Q3 | $439K | Buy |
9,186
+87
| +1% | +$4.16K | 0.32% | 107 |
|
|
2021
Q2 | $453K | Buy |
9,099
+329
| +4% | +$16.4K | 0.33% | 95 |
|
|
2021
Q1 | $391K | Buy |
+8,770
| New | +$391K | 0.36% | 103 |
|